Zhitong Financial APP learned that Guosheng Securities released a research report saying that it maintained the "buy" rating of Medical mind Health (02138), and adjusted the revenue forecast of FY2023-25 to 35.68amp 44.59 / 5.48 billion yuan based on the semi-annual report performance, while the net profit of returning to its mother was 2.26amp 3.16 / 416 million yuan. As the leader of non-public medical institutions in Hong Kong, the company builds a full-territory medical ecosystem with endogenesis and epitaxy, and releases its business potential after the epidemic, and its market share is expected to continue to increase.

According to the report, under the global economic downturn and epidemic situation, the company highlights its business resilience with a big health strategy and looks at it by plate.1)Medical services:Realized income during the period was HK $1.175 billion (yoy+47.5%), accounting for an increase of 6.9pcts to 62.1 per cent of total income. The company actively grasps the market share of local medical demand and recovers Rio Tinto's market share and tilts its core resources towards the medical services sector. during this period, the total valuation of M & An in the medical business is as high as HK $175 million, covering 35 medical disciplines and specialties. the number of full-time registered full-time doctors increased to 293.2) Aesthetics, medical treatment, beauty and health care:The realized income was 607 million Hong Kong dollars, accounting for 32.1% of the total income, mainly due to the decline in medical income caused by the suspension of business. During the period, Hong Kong and Macao closed business for 122 / 31, and only the mainland's income increased by 12.6% to HK $90 million.

The bank mentioned that the company currently has 154 service outlets, including Hong Kong / Macao / mainland in 134-4-16, with a total floor area increase of 24.1 per cent to 557000 square feet, with 69.1 per cent of the newly expanded network accounting for 69.1 per cent of medical services and 22.8 per cent of aesthetic medicine.1) Endogenous driver:With an income of HK $1.773 billion (yoy+22.8%) under efficient management, the number of customers served increased by 19.98% to 122900, of which regular customers accounted for nearly 71.6%, cross-brand consumers reached 28.1%, and the customer repurchase rate was as high as 93.7%.2) extension & cooperation:The Group has acquired PATCares, MobileMedical and other veterinary, health check-up and multi-specialist service assets one after another, with a total M & A valuation of HK $219 million. TTIPP plans to expand cooperation among external giants, strategically build a health care ecosystem, add Axa insurance partnerships, and jointly build AXA Axa Medical Center.